Directory
>
Michael Tolentino
Michael Tolentino
Clinical Associate Professor | Aviceda Therapeutics
Cambridge, Massachusetts, United States
Michael Tolentino
Summary
Michael Tolentino is a distinguished serial entrepreneur and retinal surgeon with a strong background in biotechnology and clinical research. He has made significant contributions to the field of ophthalmology, notably through his pioneering work on Vascular Endothelial Growth Factor (VEGF) at Harvard Medical School, which laid the groundwork for several FDA-approved treatments for retinal diseases. As a co-founder and chief innovation officer at multiple biopharmaceutical companies, he is at the forefront of developing novel therapies for complex conditions such as macular degeneration and tumors. His extensive clinical trial experience includes serving as principal investigator in over 160 studies, demonstrating his commitment to advancing medical science. Michael's expertise encompasses a range of areas, including drug design, immunology, and molecular biology, making him a key figure in the intersection of medicine and technology. He is also a sought-after speaker, sharing his insights on innovative treatment approaches at various conferences. Beyond his professional achievements, he has a unique blend of cultural knowledge, having studied Chinese language and culture, which enriches his global perspective in the healthcare industry.
Michael Tolentino
Work Experience
Clinical Associate Professor at
Orlando College Of Osteopathic Medicine
May 2023 - Present
Co-Founder, Chief Innovation Officer at
Aviceda Therapeutics
January 2023 - Present
Co-Founder, Acting CEO and Board Member at
Resonance Medicine, Inc.
March 2021 - Present
Board Member at
True Blue Protection
November 2019 - Present
Board Member at
Bespoke, Inc
November 2019 - Present
Co-Founder, Chief Innovation Officer and Board Member at
Aviceda Therapeutics
March 2018 - Present
Board Member at
THE MACULA STORE
November 2016 - Present
Associate Clinical Professor Ophthalmology at
The University of Central Florida Board of Trustees
June 2012 - Present
Co-Founder, Retina Surgeon at
Vision Partners LLC
May 2018 - September 2023
Co-Founder and Board Member at
Panther Pharmaceuticals, Inc.
October 2018 - August 2023
Retinal Surgeon/Partner at
The Macula Center
May 2017 - September 2022
Co-Founder, Co-director at
Blue Ocean Clinical Research
May 2018 - January 2021
Drug Development and Scientific Consultant at
Promedior
September 2008 - November 2019
Speaker at
Regeneron
January 2011 - August 2018
Director of Research/Partner/Retina Surgeon at
Center for Retina and Macular Disease
October 2004 - April 2017
Partner and Founder at
Phileosecurities
January 2010 - January 2013
Founder and CEO at
Altiokoncosystems
January 2010 - January 2012
Consultant at
Sequenom
January 2009 - January 2010
Scientific Advisor at
Pfizer, Inc.
January 2005 - January 2008
Founder at
OPKO Health, Inc.
January 2002 - January 2007
Michael Tolentino
Education
University of Pennsylvania School of Medicine, Assistant Professor Tenure Track
January 1999 - January 2005
University of Pennsylvania School of Medicine, Clinicalassistant Professor
January 2000 - January 2004
University of Pennsylvania School of Medicine, Clinical Fellowship
January 1999 - January 2001
University of Pennsylvania School of Medicine, Instructor
January 1999 - January 2000
Harvard Medical School, Post Doctoral Fellowship
January 1994 - January 1999
Harvard Medical School, Instructor
January 1996 - January 1999
Harvard Medical School, Internship
January 1993 - January 1994
UMass Chan Medical School, Md
January 1989 - January 1993
Brown University, Bachelor Of Arts - Ba
January 1984 - January 1989
Taiwan Language Institute, Language Certifiate
January 1987 - January 1987
Nankai University, Language Certificate
January 1986 - January 1987
Shanghai Normal University, College Credit
January 1986 - January 1986
deerfield academy, High School
January 1980 - January 1984
Frequently Asked Questions about Michael Tolentino
What is Michael Tolentino email address?
Michael Tolentino's primary email address is **********@avicedarx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michael Tolentino work for?
Michael Tolentino is a Clinical Associate Professor at Aviceda Therapeutics, a company specializing in Commercial physical research.
Where Michael Tolentino graduated from?
Michael Tolentino holds a degree in Cell/Cellular And Molecular Biology Division Of Gene Therapy from University of Pennsylvania School of Medicine.
How can I directly contact Michael Tolentino?
To contact Michael Tolentino directly, you can use the email address **********@avicedarx.com. Complete contact information is available upon registration with Muraena.
Who is Michael Tolentino?
Michael Tolentino is a distinguished serial entrepreneur and retinal surgeon with a strong background in biotechnology and clinical research. He has made significant contributions to the field of ophthalmology, notably through his pioneering work on Vascular Endothelial Growth Factor (VEGF) at Harvard Medical School, which laid the groundwork for several FDA-approved treatments for retinal diseases. As a co-founder and chief innovation officer at multiple biopharmaceutical companies, he is at the forefront of developing novel therapies for complex conditions such as macular degeneration and tumors. His extensive clinical trial experience includes serving as principal investigator in over 160 studies, demonstrating his commitment to advancing medical science. Michael's expertise encompasses a range of areas, including drug design, immunology, and molecular biology, making him a key figure in the intersection of medicine and technology. He is also a sought-after speaker, sharing his insights on innovative treatment approaches at various conferences. Beyond his professional achievements, he has a unique blend of cultural knowledge, having studied Chinese language and culture, which enriches his global perspective in the healthcare industry.
Michael`s contact details
**********@avicedarx.com
*****************@ucf.edu
*****@crmd.net
Colleagues
Executive Director-Research
Co-Founder & CEO
General Manager
Chief Medical Officer